These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
215 related articles for article (PubMed ID: 22173551)
1. Pharmacokinetically stabilized cystine knot peptides that bind alpha-v-beta-6 integrin with single-digit nanomolar affinities for detection of pancreatic cancer. Kimura RH; Teed R; Hackel BJ; Pysz MA; Chuang CZ; Sathirachinda A; Willmann JK; Gambhir SS Clin Cancer Res; 2012 Feb; 18(3):839-49. PubMed ID: 22173551 [TBL] [Abstract][Full Text] [Related]
2. 18F-fluorobenzoate-labeled cystine knot peptides for PET imaging of integrin αvβ6. Hackel BJ; Kimura RH; Miao Z; Liu H; Sathirachinda A; Cheng Z; Chin FT; Gambhir SS J Nucl Med; 2013 Jul; 54(7):1101-5. PubMed ID: 23670900 [TBL] [Abstract][Full Text] [Related]
3. Engineered cystine-knot peptides that bind alpha(v)beta(3) integrin with antibody-like affinities. Silverman AP; Levin AM; Lahti JL; Cochran JR J Mol Biol; 2009 Jan; 385(4):1064-75. PubMed ID: 19038268 [TBL] [Abstract][Full Text] [Related]
4. Evaluation of a (64)Cu-labeled cystine-knot peptide based on agouti-related protein for PET of tumors expressing alphavbeta3 integrin. Jiang L; Kimura RH; Miao Z; Silverman AP; Ren G; Liu H; Li P; Gambhir SS; Cochran JR; Cheng Z J Nucl Med; 2010 Feb; 51(2):251-258. PubMed ID: 20124048 [TBL] [Abstract][Full Text] [Related]
5. 111In-labeled cystine-knot peptides based on the Agouti-related protein for targeting tumor angiogenesis. Jiang L; Miao Z; Kimura RH; Silverman AP; Ren G; Liu H; Lu H; Cochran JR; Cheng Z J Biomed Biotechnol; 2012; 2012():368075. PubMed ID: 22570527 [TBL] [Abstract][Full Text] [Related]
6. 99mTc-labeled cystine knot peptide targeting integrin αvβ6 for tumor SPECT imaging. Zhu X; Li J; Hong Y; Kimura RH; Ma X; Liu H; Qin C; Hu X; Hayes TR; Benny P; Gambhir SS; Cheng Z Mol Pharm; 2014 Apr; 11(4):1208-17. PubMed ID: 24524409 [TBL] [Abstract][Full Text] [Related]
7. Functional mutation of multiple solvent-exposed loops in the Ecballium elaterium trypsin inhibitor-II cystine knot miniprotein. Kimura RH; Jones DS; Jiang L; Miao Z; Cheng Z; Cochran JR PLoS One; 2011 Feb; 6(2):e16112. PubMed ID: 21364742 [TBL] [Abstract][Full Text] [Related]
8. A Cystine Knot Peptide Targeting Integrin αvβ6 for Photoacoustic and Fluorescence Imaging of Tumors in Living Subjects. Zhang C; Kimura R; Abou-Elkacem L; Levi J; Xu L; Gambhir SS J Nucl Med; 2016 Oct; 57(10):1629-1634. PubMed ID: 27230926 [TBL] [Abstract][Full Text] [Related]
9. Targeted in vivo imaging of integrin alphavbeta6 with an improved radiotracer and its relevance in a pancreatic tumor model. Hausner SH; Abbey CK; Bold RJ; Gagnon MK; Marik J; Marshall JF; Stanecki CE; Sutcliffe JL Cancer Res; 2009 Jul; 69(14):5843-50. PubMed ID: 19549907 [TBL] [Abstract][Full Text] [Related]
10. Engineered cystine knot peptides that bind alphavbeta3, alphavbeta5, and alpha5beta1 integrins with low-nanomolar affinity. Kimura RH; Levin AM; Cochran FV; Cochran JR Proteins; 2009 Nov; 77(2):359-69. PubMed ID: 19452550 [TBL] [Abstract][Full Text] [Related]
11. A radiofluorinated divalent cystine knot peptide for tumor PET imaging. Jiang L; Kimura RH; Ma X; Tu Y; Miao Z; Shen B; Chin FT; Shi H; Gambhir SS; Cheng Z Mol Pharm; 2014 Nov; 11(11):3885-92. PubMed ID: 24717098 [TBL] [Abstract][Full Text] [Related]
12. Cystine-knot peptides engineered with specificities for α(IIb)β(3) or α(IIb)β(3) and α(v)β(3) integrins are potent inhibitors of platelet aggregation. Silverman AP; Kariolis MS; Cochran JR J Mol Recognit; 2011; 24(1):127-35. PubMed ID: 21194123 [TBL] [Abstract][Full Text] [Related]
13. Preliminary evaluation of (177)Lu-labeled knottin peptides for integrin receptor-targeted radionuclide therapy. Jiang L; Miao Z; Kimura RH; Liu H; Cochran JR; Culter CS; Bao A; Li P; Cheng Z Eur J Nucl Med Mol Imaging; 2011 Apr; 38(4):613-22. PubMed ID: 21153409 [TBL] [Abstract][Full Text] [Related]
14. Pegylated Arg-Gly-Asp peptide: 64Cu labeling and PET imaging of brain tumor alphavbeta3-integrin expression. Chen X; Hou Y; Tohme M; Park R; Khankaldyyan V; Gonzales-Gomez I; Bading JR; Laug WE; Conti PS J Nucl Med; 2004 Oct; 45(10):1776-83. PubMed ID: 15471848 [TBL] [Abstract][Full Text] [Related]
15. Evaluation of [64Cu]Cu-DOTA and [64Cu]Cu-CB-TE2A chelates for targeted positron emission tomography with an alphavbeta6-specific peptide. Hausner SH; Kukis DL; Gagnon MK; Stanecki CE; Ferdani R; Marshall JF; Anderson CJ; Sutcliffe JL Mol Imaging; 2009; 8(2):111-21. PubMed ID: 19397856 [TBL] [Abstract][Full Text] [Related]
16. Tumor targeting with radiolabeled alpha(v)beta(3) integrin binding peptides in a nude mouse model. Janssen ML; Oyen WJ; Dijkgraaf I; Massuger LF; Frielink C; Edwards DS; Rajopadhye M; Boonstra H; Corstens FH; Boerman OC Cancer Res; 2002 Nov; 62(21):6146-51. PubMed ID: 12414640 [TBL] [Abstract][Full Text] [Related]
17. Comparison of the RGD Motif-Containing α Roesch S; Lindner T; Sauter M; Loktev A; Flechsig P; Müller M; Mier W; Warta R; Dyckhoff G; Herold-Mende C; Haberkorn U; Altmann A J Nucl Med; 2018 Nov; 59(11):1679-1685. PubMed ID: 29674419 [TBL] [Abstract][Full Text] [Related]
18. A dual-labeled knottin peptide for PET and near-infrared fluorescence imaging of integrin expression in living subjects. Kimura RH; Miao Z; Cheng Z; Gambhir SS; Cochran JR Bioconjug Chem; 2010 Mar; 21(3):436-44. PubMed ID: 20131753 [TBL] [Abstract][Full Text] [Related]